Chugai Pharmaceutical: Confirmatory letter.
Chugai Pharmaceutical: Interim report - 114th Period (01/01/2024 - 12/31/2024)
Chugai Pharmaceutical: Confirmation letter
Chugai Pharmaceutical: (Correction) Partial Correction to Consolidated Financial Statements (IFRS) for the 2023 Fiscal Year (Unaudited)
Chugai Pharmaceutical: (Correction/Correction of numerical data) Correction of some parts of the "Fiscal Year ending December 2023 Consolidated Financial Statements [IFRS] (Consolidated)"
Chugai Pharmaceutical: Corrected Financial Report - 113th Term (2023/01/01 - 2023/12/31)
Chugai Pharmaceutical: Provisional linked financial statements (IFRS) (unaudited) (Q2 of fiscal year 2024)
Chugai Pharmaceutical: Supplementary information for the consolidated financial statements (IFRS) for the second quarter (interim) of the period ending in December 2024.
Chugai Pharmaceutical: Supplemental materials for the interim consolidated financial statements for the second quarter of fiscal year 2024. (IFRS 12)
Chugai Pharmaceutical: Interim financial results (IFRS) for the second quarter of December 2024. (Consolidated)
Chugai Pharmaceutical: About the interim earnings reports of F. Hoffmann-La Roche for December 2024.
Chugai Pharmaceutical: F. Hoffmann-La Roche announces half-year results for 2024.
Chugai Pharmaceutical: Notice Concerning Completion of Disposal of Own Shares as a Stock Remuneration System with Transfer Restrictions
Chugai Pharmaceutical: Notice regarding completion of payment of disposal of treasury stock as stock reward with transfer restrictions
Chugai Pharmaceutical: Confirmation letter
Chugai Pharmaceutical: Quarterly Report - 114th Quarter (2024/01/01 to 2024/03/31)
Chugai Pharmaceutical: Supplementary material on consolidated financial results for the 1st quarter of fiscal year 2024. 12 (IFRS)
Chugai Pharmaceutical: Consolidated Financial Statements (IFRS) (non-audited) (1st quarter of fiscal year 2024)
Chugai Pharmaceutical: Consolidated financial results for the 1st quarter of the fiscal year ending 2024/12 [IFRS] supplementary materials
Chugai Pharmaceutical: Summary of financial results for the 1st quarter of the fiscal year ending 2024/12 [IFRS] (consolidated)
No Data